On-Demand Cell Line Development Webinars

1. Accelerating Multispecific Biologics: Overcoming Light Chain Mispairing 10/8/2026

   Bispecific discovery depends on solving light chain mispairing without a common light chain. Retaining native IgG attributes may shorten the path from lead optimization to stable CHO cell lines.

2. Accelerating CHO Media Development: From Screening To AI Design 10/1/2026

   Discover how high-throughput screening, process analytics, and AI-guided modeling can help identify promising CHO media and feed combinations faster and support a more predictive approach.

3. IND In As Little As 6 Months: Now Beyond mAbs - Accelerating Bispecifics, Fc-Fusions And High-Concentration Biologics To The Clinic 9/25/2026

   Listen as our experts outline expanded accelerated DNA-to-IND pathways for a broader range of biologic modalities, examining how expression technologies and integrated CMC strategies can shorten development timelines.

4. Improving Scale-Up Starts With Expression Strategy 9/21/2026

   Early expression screening and strain-engineering strategies can reveal manufacturing risks and clarify which recombinant protein candidates are worth advancing before major investments are made.

5. Scaling AAV Manufacturing To 1000 L: Strategies For Robust Production 9/15/2026

   Learn how integrated cell line, media, and process design can support consistent AAV production at larger volumes while maintaining productivity and quality, as well as reducing scale-up risk.

6. De-Risking Cell Culture Media Scale-Up For Late-Stage Manufacturing 9/11/2026

   Explore practical approaches to scaling cell culture media manufacturing, from supply assurance to evolving quality requirements, digital formulation tools, and strategies for controlling costs.

7. Reducing Timelines And Development Costs Through Scale Up 9/11/2026

   See how an engineering-based approach to bioreactor scale-up delivered comparable cell growth, metabolic profiles, and product performance across cell lines and vessel sizes, helping reduce risks.

8. A Comprehensive Solution With Targeted And Non-Targeted Approaches 8/26/2026

   Explore how non-targeted NGS and targeted molecular assays can work together during cell line characterization to provide broad virus detection while supporting evolving regulatory expectations.

9. Driving Measurable Productivity Gains In CHO Cell Culture 8/25/2026

   Explore how targeted media supplementation can improve CHO cell culture outcomes, simplify process optimization, and increase productivity across monoclonal antibodies and emerging modalities.

10. Characterizing Process Performance And Robustness In An End-To-End Cryopreserved Autologous CAR-T/TCR Workflow 8/25/2026

    A systematic evaluation of an end-to-end cryopreserved CAR-T workflow examines how critical process parameters and unit operation interdependencies affect manufacturing consistency and robustness.